Dr. Shelly David Senders, M.D., Inc.

Cleveland, Ohio 44118

0 studies enrolling now · 1 studies all time

What they study most

Chronic Lung Disease

Studies at this site

• Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis) — Completed